EMBC Alert: Hagens Berman Investigates Alleged Securities Law Violations at Embecta Corp. (NASDAQ: EMBC) Following Pending Class Action Litigation

Hagens Berman is investigating Embecta regarding alleged securities law violations following a pending class action lawsuit in the U.S. District Court for the District of New Jersey. The investigation focuses on claims that the company misled investors about the stability and commercial strength of its insulin pen needle business. Investors who suffered losses between Nov.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.